Showing results (131-140 of 6,024) with videos related to

Sort By:
Pageof 603
European Journal of Pharmacology|November 19, 1991
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleepA Renaud, S Nishino, W C Dement, et al.
Brain : a Journal of Neurology|October 19, 2005
Kleine-Levin syndrome: a systematic review of 186 cases in the literatureI Arnulf, J M Zeitzer, J File, et al.
Neuroscience|April 1, 1994
Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexyM S Reid, J M Siegel, W C Dement, et al.
Brain Research|May 1, 1989
Evidence for multiple [3H]prazosin binding sites in canine brain membranesE Mignot, S S Bowersox, J Maddaluno, et al.
Neuroreport|July 31, 1995
Altered distribution of cholinergic cells in the narcoleptic dogD Nitz, A Andersen, H Fahringer, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Radioligand binding to adenosine receptors and adenosine uptake sites in different brain regions of normal and narcoleptic dogsM Hawkins, S O'Connor, M Radulovacki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsyJ Riehl, K Honda, M Kwan, et al.
Neurology|June 1, 1997
HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexyA E Rogers, J Meehan, C Guilleminault, et al.
Biological Psychiatry|May 1, 1989
Free and conjugated plasma homovanillic acid in schizophrenic patientsA Garcia, A Galinowski, P Guicheney, et al.
European Journal of Neurology|December 23, 2004
Hypocretin deficiency in Prader-Willi syndromeS Nevsimalova, J Vankova, I Stepanova, et al.
Pageof 603